EmpiRx Health, the leading clinically-driven PBM company, today announced the opening of a major new office…
Year: 2024
Novavax to Participate in 2024 Jefferies Global Healthcare Conference
Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced it…
TOOsonix receives MDR CE Mark for its new oncology and dermatology devic
TOOsonix A/S, a pioneer in high-intensity focused ultrasound (HIFU) technology for dermatology, has received EU Medical…
Precision Biologics to Present at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 1st, 2024
Precision Biologics, Inc. reports that novel findings from its ongoing phase 2 clinical trial, combining NEO-201…
CANYON RANCH CREATES A SUMMER FANTASY FOR GUESTS: “UNLIMITED SPA” PACKAGE OFFERS ENDLESS DAILY SPA SERVICES AND TREATMENTS
The ultimate fantasy spa experience becomes a reality this summer at Canyon Ranch in Tucson, where the…
The Worst Super Bowl Ads — Avoid These Blunders
While athletes gather new motivation and coaches pick up a few more techniques, the Super Bowl…
The 7 Types of Social Media and Pros & Cons of Each (Research)
When it comes to social media, I‘m quite the expert. I had to tireless scrub through…
How to Give Productive Feedback, According to HubSpot Managers & Editors
Have you ever been in a situation where one piece of feedback changed your life? I…
DeepScribe’s Ambient AI for Clinical Documentation now available on the AWS Marketplace
DeepScribe, a leader in ambient AI clinical documentation, is pleased to announce its general availability on AWS…
Marius Pharmaceuticals Announces Final Published Phase 3 Data from MRS-TU-2019EXT Studying the Safety and Efficacy of FDA-Approved KYZATREX® (testosterone undecanoate) CIII Capsules
Marius Pharmaceuticals, a pharmaceutical company focused on developing innovative therapies for testosterone deficiency, today announced published…